Literature DB >> 30199917

Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.

Luis Gustavo Perez-Rivas1, Tracy Ann Williams1,2, Martin Reincke1.   

Abstract

Primary aldosteronism is a common cause of endocrine hypertension. It results from the excess production of aldosterone by the adrenal cortex and is related to increased morbidity and mortality. Most cases of PA are sporadic but inherited patterns of the disease have been reported in the literature. Four forms of familial hyperaldosteronism (FH-I- FH-IV) are currently recognized, and the genetic basis has been clarified in recent years. In FH-I patients, aldosterone excess is produced by a CYP11B1/CYP11B2 fusion gene and it is suppressed by glucocorticoid treatment. FH-II is caused by mutations in the inwardly rectifying chloride channel CLCN2. FH-III is caused by mutations in KCNJ5, a gene coding for an inward rectifier K+ channel and mutations in the T-type calcium channel subunit CACNA1H cause FH-IV. In this review we summarize the knowledge on inherited forms of primary aldosteronism, the genetic alterations that cause them and the implications it may have for the classification. Based on current evidence, we propose the term "familial hyperaldosteronism" to refer only to inherited forms of primary aldosteronism with a known genetic basis. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30199917     DOI: 10.1055/a-0713-0629

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  7 in total

1.  Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth.

Authors:  Yuhong Yang; Celso E Gomez-Sanchez; Diana Jaquin; Elke Tatjana Aristizabal Prada; Lucie S Meyer; Thomas Knösel; Holger Schneider; Felix Beuschlein; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2019-08-26       Impact factor: 10.190

Review 2.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

3.  Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study.

Authors:  Nae Takizawa; Susumu Tanaka; Koshiro Nishimoto; Yuki Sugiura; Makoto Suematsu; Chisato Ohe; Haruyuki Ohsugi; Yosuke Mizuno; Kuniaki Mukai; Tsugio Seki; Kenji Oki; Celso E Gomez-Sanchez; Tadashi Matsuda
Journal:  Curr Issues Mol Biol       Date:  2021-12-28       Impact factor: 2.976

4.  Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma.

Authors:  Masato Mitsuda; Atsushi Shiozaki; Michihiro Kudou; Hiroki Shimizu; Tomohiro Arita; Toshiyuki Kosuga; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Eigo Otsuji
Journal:  Ann Surg Oncol       Date:  2021-02-09       Impact factor: 5.344

Review 5.  Neuronal Cav3 channelopathies: recent progress and perspectives.

Authors:  Philippe Lory; Sophie Nicole; Arnaud Monteil
Journal:  Pflugers Arch       Date:  2020-07-07       Impact factor: 3.657

6.  GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.

Authors:  Yu-Ching Wu; Chia-I Chen; Peng-Ying Chen; Chun-Hung Kuo; Yi-Hsuan Hung; Kang-Yung Peng; Vin-Cent Wu; Jyy-Jih Tsai-Wu; Chia-Lang Hsu
Journal:  BMC Bioinformatics       Date:  2022-01-10       Impact factor: 3.169

Review 7.  Molecular Mechanisms of Primary Aldosteronism.

Authors:  Sergei G Tevosian; Shawna C Fox; Hans K Ghayee
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.